Friday, April 12, 2024
HomeAI News & UpdatesAstraZeneca Teams Up with An AI Startup to Discover A Cancer Cure

AstraZeneca Teams Up with An AI Startup to Discover A Cancer Cure

The pharmaceutical business AstraZeneca, which made a vaccination for COVID-19, will team up with Absci, an AI biologics startup based in the US, to create a cancer antibody. Together, they want to build a zero-shot generative AI model that can improve and develop new antibody treatments.

An article in REUTERS dated December 3rd stated that AstraZeneca is planning to spend as much as $247 million on Absci’s R&D, milestone payments, and upfront fees. Together, they want to build a zero-shot generative AI model that can improve and develop new cancer antibody treatments. The specific cancer(s) involved were not identified in the paper.

The Absci website boasts that their AI screens “billions of cells” weekly, which allows them to get from antibodies to wet “lab-validated candidates” in just six weeks. The company is now involved in seventeen ongoing projects. Senior VP Puja Sapra of AstraZeneca has stated:

“AI is allowing us to boost the variety of biologics we find while simultaneously increasing the success and velocity of our biologics discovery process.”

The agreement was formally acknowledged by Absci CEO Sean McClain, who stated that AstraZeneca will assist in leveraging its artificial intelligence efforts (Reuters story). Absci still needs to respond to Cointelegraph’s request for additional information.

The potential for AI to greatly enhance the speed and precision of data analysis and creative research has led to its rapid adoption in the healthcare sector. The initiation of an artificial intelligence pilot to fight superbugs, or organisms that are resistant to multiple drugs, was announced in November by the Hong Kong Hospital Authority. The AI will examine patient records to ascertain whether antibiotic prescriptions are necessary, as their overuse led to the development of superbugs that are resistant to these drugs on the island.

 

 

 

Editorial Staff
Editorial Staff
Editorial Staff at AI Surge is a dedicated team of experts led by Paul Robins, boasting a combined experience of over 7 years in Computer Science, AI, emerging technologies, and online publishing. Our commitment is to bring you authoritative insights into the forefront of artificial intelligence.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments